Over the last 7 days, the Biotech industry has risen 1.4%, driven by gains from Oncolytics Biotech of 56%. In the last 12 months, the industry was up 15%. In the next few years, earnings are forecast to decline by 11% annually.
Has the Canadian Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 18 Jun 2025 | CA$1.5b | CA$90.6m | -CA$285,721,470.78 | 22.1x | -5.2x | 16.3x |
Fri, 16 May 2025 | CA$1.8b | CA$94.1m | -CA$315,443,899.26 | 22.7x | -5.6x | 18.7x |
Sun, 13 Apr 2025 | CA$1.4b | CA$92.1m | -CA$285,841,273.77 | 19.8x | -4.7x | 14.7x |
Tue, 11 Mar 2025 | CA$1.6b | CA$88.7m | -CA$325,007,445.78 | 20.6x | -4.8x | 17.5x |
Thu, 06 Feb 2025 | CA$1.6b | CA$87.5m | -CA$318,893,184.72 | 25.1x | -5x | 18.3x |
Sat, 04 Jan 2025 | CA$1.5b | CA$85.6m | -CA$323,047,850.88 | 16x | -4.6x | 17.5x |
Mon, 02 Dec 2024 | CA$1.5b | CA$83.4m | -CA$310,404,122.74 | 8.1x | -4.8x | 18x |
Wed, 30 Oct 2024 | CA$1.4b | CA$80.4m | -CA$282,244,093.37 | 8.7x | -5x | 17.7x |
Fri, 27 Sep 2024 | CA$975.6m | CA$80.2m | -CA$268,323,039.72 | 4.8x | -3.6x | 12.2x |
Sun, 25 Aug 2024 | CA$978.6m | CA$80.2m | -CA$284,326,995.83 | 9.5x | -3.4x | 12.2x |
Tue, 23 Jul 2024 | CA$1.1b | CA$76.1m | -CA$339,964,477.79 | 11.1x | -3.2x | 14.2x |
Thu, 20 Jun 2024 | CA$1.1b | CA$76.8m | -CA$339,985,305.40 | 11.1x | -3.3x | 14.6x |
Sat, 18 May 2024 | CA$1.1b | CA$77.1m | -CA$367,554,030.94 | 11.2x | -3.1x | 14.8x |
Mon, 15 Apr 2024 | CA$925.0m | CA$79.5m | -CA$301,900,009.30 | 13.1x | -3.1x | 11.6x |
Wed, 13 Mar 2024 | CA$1.1b | CA$91.6m | -CA$319,822,627.76 | 11x | -3.4x | 11.9x |
Fri, 09 Feb 2024 | CA$1.0b | CA$87.2m | -CA$323,603,166.22 | 10x | -3.2x | 11.8x |
Sun, 07 Jan 2024 | CA$3.6b | CA$86.2m | -CA$515,871,225.00 | 6.9x | -7x | 42x |
Tue, 05 Dec 2023 | CA$3.8b | CA$86.1m | -CA$542,676,059.00 | 5.4x | -6.9x | 43.6x |
Thu, 02 Nov 2023 | CA$3.7b | CA$89.1m | -CA$538,529,706.00 | 7.7x | -6.9x | 41.8x |
Sat, 30 Sep 2023 | CA$3.9b | CA$88.8m | -CA$530,758,412.00 | 6x | -7.3x | 43.7x |
Mon, 28 Aug 2023 | CA$4.0b | CA$87.4m | -CA$510,271,494.00 | 6.4x | -7.8x | 45.5x |
Wed, 26 Jul 2023 | CA$4.0b | CA$81.5m | -CA$515,987,753.00 | 13.6x | -7.8x | 49.6x |
Fri, 23 Jun 2023 | CA$4.0b | CA$86.4m | -CA$541,957,527.00 | 13.1x | -7.3x | 45.8x |
Sun, 21 May 2023 | CA$3.8b | CA$82.8m | -CA$608,966,275.00 | 11.4x | -6.2x | 45.4x |
Tue, 18 Apr 2023 | CA$2.4b | CA$83.7m | -CA$595,579,537.00 | 12.8x | -4.1x | 29x |
Thu, 16 Mar 2023 | CA$2.6b | CA$90.6m | -CA$587,559,913.00 | 8.1x | -4.5x | 29x |
Sat, 11 Feb 2023 | CA$3.0b | CA$89.0m | -CA$587,856,761.00 | 8.4x | -5.1x | 33.5x |
Mon, 09 Jan 2023 | CA$3.0b | CA$87.5m | -CA$526,225,652.00 | 11.7x | -5.7x | 34x |
Wed, 07 Dec 2022 | CA$3.3b | CA$88.6m | -CA$579,892,466.00 | 7.1x | -5.7x | 37x |
Fri, 04 Nov 2022 | CA$3.1b | CA$86.1m | -CA$570,554,197.00 | 13x | -5.4x | 35.6x |
Sun, 02 Oct 2022 | CA$3.3b | CA$86.1m | -CA$550,520,366.00 | 13.5x | -6.1x | 38.7x |
Tue, 30 Aug 2022 | CA$3.5b | CA$81.6m | -CA$535,448,590.00 | 13.9x | -6.5x | 42.6x |
Thu, 28 Jul 2022 | CA$3.2b | CA$87.3m | -CA$564,237,342.00 | 11.3x | -5.7x | 36.8x |
Sat, 25 Jun 2022 | CA$3.1b | CA$181.5m | -CA$607,227,399.00 | 12.5x | -5x | 16.9x |
-5x
How does Canadian Biotech compare with similar industries?
CA Market | 0.41% | |
Healthcare | -1.43% | |
Biotech | 1.38% | |
Biotech | 1.38% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ONC Oncolytics Biotech | CA$1.01 | 32.9% +CA$22.2m | -27.3% | PB13.8x | |
EPRX Eupraxia Pharmaceuticals | CA$5.84 | 9.4% +CA$17.9m | 68.3% | PE-5.6x | |
RKV Rakovina Therapeutics | CA$0.055 | -8.3% CA$3.2m | -47.6% | PB4.9x | |
COV Covalon Technologies | CA$2.40 | 2.1% +CA$1.4m | 11.1% | PE17.8x | |
MPH Medicure | CA$1.16 | 9.4% +CA$1.0m | 6.4% | PS0.6x |